56.05
price up icon0.04%   0.02
after-market アフターアワーズ: 56.10 0.05 +0.09%
loading
前日終値:
$56.03
開ける:
$56.48
24時間の取引高:
1.44M
Relative Volume:
0.57
時価総額:
$10.37B
収益:
$2.69B
当期純損益:
$-214.04M
株価収益率:
-47.91
EPS:
-1.17
ネットキャッシュフロー:
$98.43M
1週間 パフォーマンス:
+0.13%
1か月 パフォーマンス:
-0.25%
6か月 パフォーマンス:
+22.70%
1年 パフォーマンス:
-14.30%
1日の値動き範囲:
Value
$55.37
$57.23
1週間の範囲:
Value
$54.45
$57.26
52週間の値動き範囲:
Value
$40.62
$79.62

Exact Sciences Corp Stock (EXAS) Company Profile

Name
名前
Exact Sciences Corp
Name
セクター
Healthcare (1173)
Name
電話
608-284-5700
Name
住所
5505 ENDEAVOR LANE, MADISON, WI
Name
職員
6,600
Name
Twitter
@exactsciences
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
EXAS's Discussions on Twitter

EXAS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
56.05 10.37B 2.69B -214.04M 98.43M -1.17
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
597.75 228.64B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
222.74 160.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
151.52 43.27B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.36 36.55B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
422.05 34.56B 3.84B 866.24M 792.60M 10.37

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-23 開始されました Barclays Overweight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Buy
2024-01-02 アップグレード The Benchmark Company Hold → Buy
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-10 アップグレード Piper Sandler Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-08-02 ダウングレード The Benchmark Company Buy → Hold
2023-05-10 アップグレード Craig Hallum Hold → Buy
2023-05-05 開始されました UBS Neutral
2023-03-09 アップグレード Citigroup Neutral → Buy
2023-02-10 ダウングレード Credit Suisse Outperform → Neutral
2023-01-18 ダウングレード Raymond James Outperform → Mkt Perform
2022-10-19 ダウングレード Craig Hallum Buy → Hold
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Neutral
2021-11-03 ダウングレード Raymond James Strong Buy → Outperform
2021-07-29 繰り返されました BTIG Research Buy
2021-07-29 繰り返されました Canaccord Genuity Buy
2021-07-29 繰り返されました Oppenheimer Outperform
2021-07-29 繰り返されました Stifel Buy
2021-06-15 開始されました Raymond James Strong Buy
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Equal Weight
2021-01-28 開始されました Truist Buy
2020-10-29 ダウングレード UBS Buy → Neutral
2020-10-28 ダウングレード Citigroup Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-04-02 開始されました Evercore ISI Outperform
2020-01-10 再開されました BTIG Research Buy
2020-01-07 開始されました Citigroup Buy
2019-12-13 開始されました Dougherty & Company Buy
2019-11-15 開始されました Stifel Buy
2019-10-17 繰り返されました BofA/Merrill Buy
2019-10-01 再開されました Craig Hallum Buy
2019-09-26 開始されました Oppenheimer Outperform
2019-02-26 アップグレード Goldman Neutral → Buy
2018-10-09 開始されました UBS Buy
2018-09-05 再開されました The Benchmark Company Hold
2018-08-13 繰り返されました Canaccord Genuity Buy
2018-04-03 アップグレード BTIG Research Neutral → Buy
2018-01-29 開始されました Goldman Neutral
2018-01-08 繰り返されました The Benchmark Company Buy
2017-11-13 ダウングレード Robert W. Baird Outperform → Neutral
2017-11-01 ダウングレード BTIG Research Buy → Neutral
すべてを表示

Exact Sciences Corp (EXAS) 最新ニュース

pulisher
Jan 30, 2025

Baader Bank Aktiengesellschaft Buys New Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 30, 2025
pulisher
Jan 28, 2025

Slow Capital Inc. Grows Stake in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 28, 2025
pulisher
Jan 24, 2025

Exact Sciences to launch Oncodetect MRD test in Q2 2025 - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Beacon Investment Advisory Services Inc. Sells 26,980 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Barclays Initiates Coverage of Exact Sciences (EXAS) with Overweight Recommendation - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Assenagon Asset Management S.A. Buys 12,912 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Forecasting The Future: 19 Analyst Projections For Exact Sciences - Benzinga

Jan 23, 2025
pulisher
Jan 23, 2025

Barclays sets Exact Sciences stock price target at $70 with Overweight rating - Investing.com

Jan 23, 2025
pulisher
Jan 23, 2025

Exact Sciences Q4 EPS Estimate Reduced by Leerink Partnrs - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Exact Sciences (NASDAQ:EXAS) Now Covered by Analysts at Barclays - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Brokers Set Expectations for Exact Sciences FY2026 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Leerink Partnrs Lifts Earnings Estimates for Exact Sciences - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Exact Sciences post positive results from MRD trial - Yahoo Finance

Jan 22, 2025
pulisher
Jan 21, 2025

Exact Sciences to launch Oncodetect MRD test in Q2 2025 By Investing.com - Investing.com South Africa

Jan 21, 2025
pulisher
Jan 21, 2025

Exact Sciences (EXAS): New Evidence Validates Oncodetect's Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients - StreetInsider.com

Jan 21, 2025
pulisher
Jan 21, 2025

New Evidence Validates Oncodetect's Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients - Business Wire

Jan 21, 2025
pulisher
Jan 21, 2025

Exact Sciences (NASDAQ:EXAS) Trading Up 5%Time to Buy? - MarketBeat

Jan 21, 2025
pulisher
Jan 20, 2025

Exact Sciences showcases early cancer detection test data at AACR meeting - MSN

Jan 20, 2025
pulisher
Jan 20, 2025

Avanza Fonder AB Acquires Shares of 19,512 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 20, 2025
pulisher
Jan 19, 2025

5,782 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Retirement Wealth Solutions LLC - MarketBeat

Jan 19, 2025
pulisher
Jan 18, 2025

Brookstone Capital Management Decreases Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Exact Sciences (NASDAQ:EXAS) Stock Price Down 4.3%What's Next? - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Why Exact Sciences (EXAS) Is Crashing? - Insider Monkey

Jan 17, 2025
pulisher
Jan 16, 2025

Exact Sciences Stock Drops 12% Over Four Days. 'What Is Going On?' - Yahoo! Voices

Jan 16, 2025
pulisher
Jan 16, 2025

Beech Hill Advisors Inc. Sells 11,383 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

2 Healthcare Stocks to Buy Hand Over Fist in January - Yahoo Finance

Jan 16, 2025
pulisher
Jan 15, 2025

Exact Sciences (NASDAQ:EXAS) Shares Gap UpStill a Buy? - MarketBeat

Jan 15, 2025
pulisher
Jan 14, 2025

Exact Sciences (NASDAQ:EXAS) Trading Down 4.3%Here's Why - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

William Blair Reaffirms "Outperform" Rating for Exact Sciences (NASDAQ:EXAS) - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Exact Sciences Stock Surges with Strong Financials - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market - Benzinga

Jan 13, 2025
pulisher
Jan 13, 2025

Exact Sciences (NASDAQ:EXAS) Given Buy Rating at Benchmark - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Exact Sciences Boosts Finances and Plans New Launches - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Exact Sciences expects Q4 and FY revenue to beat estimates - MSN

Jan 13, 2025
pulisher
Jan 12, 2025

Exact Sciences Reports 10% Revenue Jump to $713M, Plans Three New Cancer Tests for 2025 - StockTitan

Jan 12, 2025
pulisher
Jan 12, 2025

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results - Yahoo Finance

Jan 12, 2025
pulisher
Jan 11, 2025

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Harbor Capital Advisors Inc. - MarketBeat

Jan 11, 2025
pulisher
Jan 08, 2025

Q2 EPS Estimate for Exact Sciences Increased by Analyst - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Should Exact Sciences Stock Stay in Your Portfolio Right Now? - Yahoo Finance

Jan 08, 2025
pulisher
Jan 08, 2025

Exact Sciences Co. (NASDAQ:EXAS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

Exact Sciences Corporation Announces Appointment of Kim Popovits as A Class I Member of the Board - Marketscreener.com

Jan 07, 2025
pulisher
Jan 04, 2025

Exact Sciences to participate in J.P. Morgan Healthcare Conferen - GuruFocus.com

Jan 04, 2025
pulisher
Jan 03, 2025

Exact Sciences price target raised to $70 from $60 at Evercore ISI - Yahoo Finance

Jan 03, 2025
pulisher
Jan 02, 2025

Exact Sciences to Participate in J.P. Morgan Healthcare Conference - Marketscreener.com

Jan 02, 2025
pulisher
Jan 02, 2025

Exact Sciences to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 02, 2025
pulisher
Jan 01, 2025

Exact Sciences Announces Second-Quarter 2023 Results - GuruFocus.com

Jan 01, 2025
pulisher
Jan 01, 2025

Exact Sciences Co. (NASDAQ:EXAS) Short Interest Down 5.3% in December - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

(EXAS)Analyzing Exact Sciences's Short Interest - Benzinga

Dec 31, 2024
pulisher
Dec 26, 2024

Exact Sciences Corporation's (NASDAQ:EXAS) Shift From Loss To Profit - Simply Wall St

Dec 26, 2024
pulisher
Dec 22, 2024

Principal Financial Group Inc. Has $71.48 Million Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 22, 2024
pulisher
Dec 16, 2024

Tidal Investments LLC Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 16, 2024

Exact Sciences Corp (EXAS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$249.80
price down icon 0.69%
$132.74
price down icon 0.20%
$176.92
price up icon 0.37%
diagnostics_research WAT
$415.48
price down icon 0.43%
diagnostics_research MTD
$1,364.44
price down icon 0.00%
$422.05
price down icon 0.46%
大文字化:     |  ボリューム (24 時間):